Page 65 - Bsx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bsx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moors & Cabot Inc. lessened its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 2.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 32,131 shares of the medical equipment provider’s stock after selling 777 shares during the quarter. Moors & Cabot Inc.’s holdings in Boston Scientific were worth […] ....
Boston Scientific (NYSE:BSX – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.90-1.96 for the period, compared to the consensus earnings per share estimate of $1.91. The company issued revenue guidance of ~$13.76-14.01 billion, compared to the consensus revenue estimate of $13.54 billion. Boston Scientific also […] ....
Boston Scientific (NYSE:BSX – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided EPS guidance of $0.48-$0.50 for the period, compared to the consensus EPS estimate of $0.48. The company issued revenue guidance of $3.46 billion-$3.52 billion, compared to the consensus revenue estimate of $3.44 billion. Boston Scientific also updated […] ....
Retirement Systems of Alabama trimmed its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 67.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 458,857 shares of the medical equipment provider’s stock after selling 963,653 shares during the […] ....
Boston Scientific (NYSE:BSX – Get Rating) had its target price upped by stock analysts at Royal Bank of Canada from $53.00 to $56.00 in a report issued on Thursday, The Fly reports. Royal Bank of Canada’s target price would indicate a potential upside of 8.91% from the company’s current price. A number of other research […] ....